Literature DB >> 34237398

Successful management of refractory ascites in non-TIPSable patients using percutaneous thoracic duct stenting.

Julien Ghelfi1, Bleuenn Brusset2, Frederic Thony3, Thomas Decaens2.   

Abstract

Entities:  

Keywords:  Cirrhosis; lymphatic intervention; lympho-venous junction; portal hypertension; stent

Mesh：

Year:  2021        PMID： 34237398     DOI： 10.1016/j.jhep.2021.06.033

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  2 in total

1.  Management of chyluria using percutaneous thoracic duct stenting.

Authors:  Nguyen Ngoc Cuong; Le Tuan Linh; Thieu Thi Tra My; Tran Quoc Hoa; Hoang Long; Le Hoan; Masanori Inoue
Journal:  CVIR Endovasc       Date:  2022-10-19

2.  Cisterna chyli as an optimal marker of tolvaptan response in severe cirrhotic ascites.

Authors:  Masashi Hirooka; Yohei Koizumi; Ryo Yano; Yoshiko Nakamura; Koutarou Sunago; Atsushi Yukimoto; Takao Watanabe; Osamu Yoshida; Yoshio Tokumoto; Masanori Abe; Yoichi Hiasa
Journal:  Sci Rep       Date:  2022-05-17       Impact factor: 4.996
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.